Zobrazeno 1 - 10
of 12
pro vyhledávání: '"Stanisław, Maj"'
Autor:
Stanisław Maj
Publikováno v:
Nasza Przeszłość, Vol 132 (2019)
Do tej pory brak osobnej biografii biskupa Michała Korczyńskiego, pomimo tego, że dobrze zasłużył się dla Kościoła i dla Polski. Niniejszy szkic jest pierwszą próbą opracowania takiej biografii. Zebrałem w nim rozproszone na ogół infor
Externí odkaz:
https://doaj.org/article/3047091751d24856b2dcfec6dcf2d962
Autor:
Sławomira Krzemień, Wojciech Baran, Maria Cioch, Aleksander B. Skotnicki, Stanisław Maj, Beata Hołowiecka, Sebastian Giebel, Jerzy Wojnar, Lech Konopka, Małgorzata Kopera, Tadeusz Robak, Małgorzata Krawczyk-Kuliś, Jerzy Holowiecki, Sebastian Grosicki, Anna Dmoszynska, Monika Paluszewska, Krystyna Jagoda, Andrzej Hellmann, Wojciechowska M
Publikováno v:
Leukemia & Lymphoma. 43:315-325
Sixty-four untreated adult acute lymphoblastic leukemia (ALL) patients were randomized to receive chemotherapy alone, n = 31 or chemotherapy and granulocyte colony stimulating factor (G-CSF), n = 33. During induction patients received G-CSF for 5 day
Autor:
M. Kazimierczak, S. Kotlarek-Haus, Tadeusz Robak, L Usnarska-Zubkiewicz, Andrzej Hellmann, Z. Kuratowska, Barbara Zdziarska, M Błasińska-Morawiec, Paweł Grieb, Jadwiga Dwilewicz-Trojaczek, Jan Maciej Zaucha, E. Krykowski, J. Hołowiecki, L Urasiński, J. Hansz, M. Krawczyk-Kulis, Stanisław Maj, M Komarnicki, Lech Konopka
Publikováno v:
Leukemia & Lymphoma. 22:107-111
Forty one patients with hairy cell leukemia (HCL) were treated with 2-chloro-deoxyadenosine (2-CdA) administered in various schedules. Complete remission (CR) was achieved in 31 (76%) patients and partial remission (PR) in 9 (22%). The mean duration
Publikováno v:
Acta poloniae pharmaceutica. 63(5)
Autor:
Izabella, Kopeć, Romuald, Debski, Marzena, Samsel, Waldemar, Winter, Renata, Maryniak, Monika, Prochorec, Urszula, Podstawka, Stanisław, Maj, Zbigniew, Banaczek, Krzysztof, Warzocha
Publikováno v:
Ginekologia polska. 76(11)
Pregnancy complicated by HCL is an extremlely rare event: only 5 report of HCL in pregnancy have been previously described. A 36-year-old women was diagnosed of HCL presented in 14 week of her 5th pregnancy. Therapy was initiated in 18 wk of gestatio
Autor:
Zdzisława Traczyk, Ewa Zdebska, Ewa Pszenna, Witold Danikiewicz, Gabriela Smoleńska-Sym, Jerzy Kościelak, Justyna Spychalska, Stanisław Maj, Jolanta Woźniak, Tomasz Bieńkowski
Publikováno v:
Blood cells, moleculesdiseases. 33(1)
Leukemic cells were used as experimental material to demonstrate changes in the content of GSLs during the development and maturation of neutrophils. The most abundant cellular GSL is LacCer. An elevation in the LacCer level occurs twice during the m
Autor:
Stanisław, Maj, Piotr, Centkowski
Publikováno v:
Medical science monitor : international medical journal of experimental and clinical research. 10(9)
Metamizole is a common analgesic and antipyretic drug. However, its use has been associated with a risk of side-effects involving agranulocytosis and aplastic anemia. These reactions are rare and unpredictable. The aim of this prospective study was t
Autor:
Maria, Kraj, Ryszard, Pogłód, Stanisław, Maj, Jan, Pawlikowski, Urszula, Sokołowska, Janusz, Szczepanik
Publikováno v:
Acta poloniae pharmaceutica. 59(6)
Osteolytic bone destruction, caused by the aberrant production and activation of osteoclasts, results in significant morbidity for patients with multiple myeloma (MM). Pamidronate [(3-amino-1-hydroxypropylidene)-1,1-bis-phosphonate] inhibits osteocla
Autor:
Urszula Mokras, Gabriela Smoleńska-Sym, Stanisław Maj, Ewa Zdebska, Ewa Gołaszewska, Jolanta Woźniak, Tomasz Durżyński, Jerzy Kościelak
Publikováno v:
Acta biochimica Polonica. 45(2)
Leukemic leukocytes from 12 patients with acute myelogenous leukemia (AML) and two patients with chronic myelogenous leukemia (CML) were isolated by centrifugations in Percoll gradients, and examined for total carbohydrates. In leukemic leukocytes fr
Autor:
Lech Konopka, A. Skotnicki, Z. Kuratowska, Stanisław Maj, M. Krawcyzk, Andrzej Hellmann, Anna Dmoszynska, Rudzka E, J. Holowiecki, B. Holowiecka, S. Krzemien, E. Krykowski
Publikováno v:
Acute Leukemias VI ISBN: 9783642643798
The aim of study was to evaluate the efficacy and tolerability of the the idarubicin, cytarabine (ara-C), and etoposide (ICE) remission induction protocol in comparison to the modified, risk-adjusted daunorubicin(DNR) and ara-C (DA) schedule. Fifty-s
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::5572b29b3186a8ec555f076c6c225cf6
https://doi.org/10.1007/978-3-642-60377-8_127
https://doi.org/10.1007/978-3-642-60377-8_127